Alcon Research, Ltd. v. Apotex Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
MOORE, Circuit Judge.
Apotex Inc. and Apotex Corp. (collectively, Apotex) submitted an Abbreviated New Drug Application (ANDA) to the Food and Drug Administration seeking approval to market a generic version of the anti-allergy eye drop Patanol®. Alcon Research, Ltd. et al. (collectively, Alcon), who market Patanol®, sued Apotex for patent infringement under 35 U.S.C. § 271(e)(2)(A). Alcon asserted claims 1-8 of U.S. Patent No. 5,641,805 ('805 patent), which is listed in the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) entry for Patanol®. For the reasons set…
2Cases cited11 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Ak Steel Corporation v. Sollac and Ugine, Defendants-CrossCourt of Appeals for the Federal Circuit · 2003
- In Re KubinCourt of Appeals for the Federal Circuit · 2009
6 more not listed; retrieve them via the Exa API.
3Cited by38 opinions
- Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2014
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
- Monsanto Technology LLC v. E.I. Dupont De Nemours & Co.Court of Appeals for the Federal Circuit · 2018
- Insite Vision Incorporated v. Sandoz, Inc.Court of Appeals for the Federal Circuit · 2015
- ABS Global, Inc. v. Inguran, LLCCourt of Appeals for the Seventh Circuit · 2019
33 more not listed; retrieve them via the Exa API.